SCHEMBL23710146

SCHEMBL23710146

CNCC1CCCN(C=O)C1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KB1 P23443 1/20 0.34
AKT1 P31749 1/20 0.34
ADH1B P00325 1/20 0.34
ADH1C P00326 1/20 0.34
ADH1A P07327 1/20 0.34
ADH4 P08319 1/20 0.34
ADH7 P40394 1/20 0.34
CARM1 Q86X55 1/20 0.34
PRMT6 Q96LA8 1/20 0.34
ROCK2 O75116 1/20 0.33
ROCK1 Q13464 1/20 0.33
CDC42BPB Q9Y5S2 1/20 0.33
SIGMAR1 Q99720 1/20 0.32
ITGB3 P05106 1/20 0.31
ITGA2B P08514 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.30
POLB P06746 1/20 0.30
KMT2A Q03164 1/20 0.30
DPP4 P27487 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23710266 0.82 ADH1B (0.32) ADH1BADH1CADH1AADH4ADH7
SCHEMBL24920853 0.82
SCHEMBL24170781 0.81 DPP4 (0.33) ADH1BADH1CADH1AADH4ADH7
SCHEMBL23710141 0.81 DPP4 (0.33) ADH1BADH1CADH1AADH4ADH7
SCHEMBL23710051 0.81 DPP4 (0.33) ADH1BADH1CADH1AADH4ADH7
SCHEMBL24920855 0.79 L3MBTL1 (0.38) ADH1BADH1CADH1AADH4ADH7
SCHEMBL13783474 0.79 BCHE (0.33)
SCHEMBL2885366 0.76 CHRM2 (0.38) RPS6KB1AKT1CARM1PRMT6ROCK2
SCHEMBL19575592 0.76 CHRM2 (0.38) RPS6KB1AKT1CARM1PRMT6ROCK2
SCHEMBL24920712 0.76 NPSR1 (0.34) POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023006097-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER 海创药业股份有限公司 2023-02-02 WO disclosed
EP-3858832-A1 TRIFLUOROMETHYL-SUBSTITUTED SULFONAMIDE AS BCL-2-SELECTIVE INHIBITOR Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) 2021-08-04 EP disclosed